Literature DB >> 9311486

Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia.

A G Agustí1, B Togores, J Ibañez, J M Raurich, A Maimó, J Bergada, P Marse, R Jorda.   

Abstract

Covert tissue hypoxia, particularly of the splanchnic region, appears important in the pathogenesis of multiple organ failure (MOF). This investigation evaluates the effects of N-acetylcysteine (NAC) upon several measures of tissue oxygenation in 10 patients with severe MOF and evidence of splanchnic hypoxia (as suggested by a pathologically low value (< 7.32) of the pH of the gastric mucosa (pHi)). Patients were studied following a prospective, randomized, placebo-controlled, cross-over design. Measurements included pulmonary and systemic haemodynamics, cardiac output by thermodilution, arterial and mixed venous blood gas values, blood lactate concentration, whole-body oxygen uptake by analysis of the expired gases, and pHi by tonometry. A complete set of measurements was obtained before and 45 min after the infusion of NAC (150 mg.kg-1 in 250 mL of saline) and, also, before and 45 min after the infusion of an equivalent volume of saline. NAC increased the cardiac index and vasodilated the systemic circulation (p < 0.01). However, O2 delivery to the tissues did not increase because the arterial oxygen content fell after NAC (p < 0.01). Mean O2 extraction or lactate concentration did not change after NAC, and pHi fell slightly (from 7.11 +/- 0.21 to 7.07 +/- 0.21; p < 0.05). The infusion of saline did not modify any variable significantly. The O2 extraction fraction increased exponentially in those patients with reduced O2 transport to the tissues. These results argue against a beneficial effect of N-acetylcysteine upon tissue oxygenation in patients with severe multiple organ failure and evidence of splanchnic hypoxia. Furthermore, they suggest that the mechanisms controlling the extraction of oxygen by the peripheral tissues in these patients were not impaired.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311486     DOI: 10.1183/09031936.97.10091962

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

2.  NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome.

Authors:  Laura C Whitmore; Kelli L Goss; Elizabeth A Newell; Brieanna M Hilkin; Jessica S Hook; Jessica G Moreland
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-02       Impact factor: 5.464

3.  N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.

Authors:  Prakaykaew Charunwatthana; M Abul Faiz; Ronnatrai Ruangveerayut; Richard J Maude; M Ridwanur Rahman; L Jackson Roberts; Kevin Moore; Emran Bin Yunus; M Gofranul Hoque; Mahatab Uddin Hasan; Sue J Lee; Sasithon Pukrittayakamee; Paul N Newton; Nicholas J White; Nicholas P J Day; Arjen M Dondorp
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 4.  N-acetylcysteine for sepsis and systemic inflammatory response in adults.

Authors:  Tamas Szakmany; Balázs Hauser; Peter Radermacher
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

5.  Evaluation of the Effect of Nebulized N-Acetylcysteine on Respiratory Secretions in Mechanically Ventilated Patients: Randomized Clinical Trial.

Authors:  Seyed Masoom Masoompour; Amir Anushiravani; Amir Tafaroj Norouz
Journal:  Iran J Med Sci       Date:  2015-07

6.  N-acetylcysteine in clinical sepsis: a difficult marriage.

Authors:  Herbert Spapen
Journal:  Crit Care       Date:  2004-06-09       Impact factor: 9.097

7.  Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia.

Authors:  Bulent Ergin; Philippe Guerci; Lara Zafrani; Frank Nocken; Asli Kandil; Ebru Gurel-Gurevin; Cihan Demirci-Tansel; Can Ince
Journal:  Intensive Care Med Exp       Date:  2016-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.